Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1981-03-20
1983-01-25
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
424170, 424172, 424365, A61K 31695, A61K 4700
Patent
active
043703194
ABSTRACT:
Skin conditioning compositions comprising an alkali metal phosphoric acid ester salt of a partial glyceride, silicone fluid, a long chain alkyl ester of a fatty acid, an emollient material, an emulsifier and water. The phosphated glyceride and the dimethicone fluid serve to provide greater retention of the conditioning composition on the skin.
REFERENCES:
patent: Re29814 (1978-10-01), Snyder
patent: 3681412 (1972-08-01), Betzing
patent: 3875196 (1975-04-01), Meguro et al.
patent: 3959491 (1976-05-01), Young et al.
patent: 4104403 (1978-08-01), Barker et al.
patent: 4160773 (1979-07-01), Eibl et al.
Scher Chemicals, Inc., Technical Bulletons SG0202, 0208 and 0211, available to the public approximately Jan., 1977.
Chapin Carole N.
Kelm Gary R.
Shelton David L.
Gorman John V.
Mohl Douglas C.
Moyer Donald B.
The Procter & Gamble & Company
Witte Richard C.
LandOfFree
Skin conditioning compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Skin conditioning compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Skin conditioning compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1623639